Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. 

Our core business sectors include custom synthesis and Generic API manufacturing. 
The manufacturing site is located in Cameri, Italy.  This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.

We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.

Pharmaceutical

Manufacturing

Life Sciences

PROCOS S.P.A. (CBC Group)

Enrico Zodio

Christian Belussi

Yoshihiro Furukawa

Nicolò Rubino

Kingo Yamashita

The Research and Development team at Procos S.p.A. is responsible for innovating and optimizing the development of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. This includes activities such as process development, scale-up, safety assessments, and analytical development to ensure compliance with cGMP standards. The team's expertise supports both custom synthesis projects and the manufacturing of generic APIs, ensuring the company remains a leader in pharmaceutical innovation and production.

Research and Development

Sales and Business Development Team

Leadership Team

Research and Development

About

Team members

Other teams at PROCOS S.P.A. (CBC Group)

Sales and Business Development Team

Leadership Team